Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 01 March 2020 |
| Author/s |
author: Noboru Hattori Takeshi Masuda Nobuhisa Ishikawa Yasushi Horimasu Kazunori Fujitaka |
| Publication date | March 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |